Overcoming the Greatest Barriers in Rare Disease Patient Recruitment
Every missed patient in a rare disease clinical trial represents more than a recruitment challenge, it represents a missed opportunity...
Four Key Considerations for Recruiting an Undiagnosed Population
For many patients, the journey to a clinical trial does not begin with a diagnosis, it begins with unanswered questions....
Supporting Complex Phase I Studies Through Integrated Imaging and Specialized Assessments
Medpace has expanded its integrated imaging and specialized assessment capabilities to continue supporting complex Phase I studies. Learn how this approach supports participants and study…
Upcoming Webinar: Advancing Patient and Caregiver-Centered Approaches in Neurodegenerative Clinical Trials
Neurodegenerative clinical trials present unique challenges that extend beyond scientific and operational complexity. Disease progression, caregiver responsibilities, travel burden, complex...
Inside the Lab: Advancing Clinical Laboratory Science Through Collaboration – Q&A with John M. Robbins, PhD
I was attracted to the opportunity to develop clinical skill sets in laboratory medicine while remaining grounded in the laboratory...
What Trends are Shaping Rheumatology Clinical Development in 2026?
The rheumatology landscape continues to evolve as new therapies, technologies, and strategies transform drug development. Many of these advances in...
Retina Development: The Next Era of Precision Therapies Is Here
Retina development continues to be driven by converging scientific, demographic, and commercial forces. With a rapidly growing patient population, and strong investor interest, there is a push for more assets into…
Inside the Lab: Advancing Clinical Trials Across Asia-Pacific and Greater China – Q&A with Paul Tan, PhD
Fulfilling my childhood dream of working in the clinical trial industry. I remember reading a book about clinical trials and...
Alport Research Hub Symposium: From Bench to Bedside
Discover key insights from the third Alport Research Hub Symposium and learn how Medpace's expertise advances rare nephrology research.
Behind the Breakthroughs: Rare Disease Q&A with Lauren Shannon
In this Q&A, Lauren Shannon discusses her experience and the role that Medpace plays in advancing innovative rare disease therapies.